CareCloud, Inc.
NASDAQ:CCLDMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $101.27M
- Beta
- 1.51
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.23
Volume 0.53M
Average 0.58M
CCLD Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
CareCloud, Inc.NASDAQ: CCLD
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 7.7% from a year ago
Total equity stood at $58.33M at the end of Q1 FY2026, up 7.7% from a year earlier and down 2.0% from the prior quarter. Over 3 fiscal years it compounded at -16.4% a year.
Context
- Total equity amounted to 67.3% of total assets at the end of Q1 FY2026, down 6.4 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +7.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 59.51M USD
- Year-over-year change
- +19.6%
- 4-year CAGR
- -11.7%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 59.51M | +19.6% |
| FY2024 | 2024-12-31 | 49.77M | +19.3% |
| FY2023 | 2023-12-31 | 41.72M | -59.0% |
| FY2022 | 2022-12-31 | 101.69M | +3.8% |
| FY2021 | 2021-12-31 | 97.93M | — |
Total Equity vs competitors
How CCLD compares with its peers on the latest reported figures
- CCLD's Mar 2026 total equity of $58.33M is the 2nd highest of the 10 companies compared; the peer median is $13.09M.
- Its year-over-year change of +7.7% is the 5th highest of 9, against a peer median of +0.3%.
- Total equity amounts to 67.3% of total assets for CCLD, versus a peer median of 32.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $241.48M | -22.4% | -16.6% | 88.7% | |
| Mar 2026 | $58.33M | +7.7% | -16.4% | 67.3% | |
| Mar 2026 | $23.19M | +135.3% | +19.4% | 78.1% | |
| Mar 2026 | $20.4M | -68.9% | -41.3% | 32.7% | |
| Mar 2026 | $15.49M | -22.3% | -22.7% | 26.8% | |
| Mar 2026 | $13.09M | +23.0% | -26.8% | 20.8% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $6.12M | — | — | 32.8% |
| Mar 2026 | $4M | +174.4% | -22.0% | 11.7% | |
IRDOpus Genetics, Inc. | Mar 2026 | -$45.84M | -1003.5% | -30.8% | 68.6% |
| Mar 2026 | -$227.98M | +29.3% | — | 122.3% | |
| Peer median (excluding CCLD) | $13.09M | +0.3% | -22.7% | 32.8% | |
Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 9.34M | 12.3M | 3.33M | 5.15M | 3.12M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 21.73M | 19.17M | 17M | 17.12M | 18.74M |
| Inventory | 503K | 381K | 465K | 574K | 507K |
| Other Current Assets | 1.01M | 16K | 2.45M | 1.96M | 3.37M |
| Total Current Assets | 35.56M | 34.65M | 23.24M | 24.8M | 25.74M |
| Property, Plant & Equipment (Net) | 12.34M | 9.98M | 9.68M | 8.42M | 10.88M |
| Goodwill | 61.19M | 61.19M | 19.19M | 19.19M | 31.44M |
| Intangible Assets | 30.78M | 29.52M | 25.07M | 18.7M | 18.97M |
| Long-term Investments | (765K) | (1.03M) | 0 | 0 | 0 |
| Tax Assets | 765K | 1.03M | 0 | 0 | 0 |
| Other Non-current Assets | 981K | 838K | 641K | 507K | 569K |
| Total Non-current Assets | 105.29M | 101.52M | 54.58M | 46.81M | 61.86M |
| Total Assets | 140.85M | 136.17M | 77.83M | 71.61M | 87.6M |
| Account Payables | 5.95M | 5.68M | 5.8M | 4.57M | 6.94M |
| Short-term Debt | 344K | 319K | 292K | 310K | 728K |
| Tax Payables | 934K | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.09M | 1.39M | 1.38M | 1.21M | 4.15M |
| Other Current Liabilities | 13.04M | 8.49M | 3.44M | 1.82M | 5.05M |
| Total Current Liabilities | 29.56M | 22.4M | 23.3M | 19.58M | 24.42M |
| Long-term Debt | 8.02M | 8.01M | 10.04M | 26K | 441K |
| Deferred Tax Liabilities | 449K | 525K | 0 | 0 | 966K |
| Deferred Revenue (Non-current) | 341K | 342K | 256K | 387K | 809K |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | (734K) |
| Total Non-current Liabilities | 13.36M | 12.09M | 12.81M | 2.26M | 3.67M |
| Total Liabilities | 42.92M | 34.49M | 36.11M | 21.84M | 28.09M |
| Common Stock | 16K | 16K | 17K | 17K | 43K |
| Retained Earnings | (31.05M) | (25.62M) | (74.48M) | (66.63M) | (55.83M) |
| Accumulated OCI | (1.75M) | (3.04M) | (3.87M) | (4M) | (3.98M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 97.93M | 101.69M | 41.72M | 49.77M | 59.51M |
| Total Debt | 16.87M | 13.81M | 14.73M | 3.47M | 4.28M |
| Net Debt | 7.53M | 1.51M | 11.4M | (1.68M) | 1.17M |
CareCloud, Inc.
NASDAQ:CCLD
Intrinsic Alpha fair value
Locked
Current Price
$2.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.